Home » Topics » Regulatory » Patents

Patents
RSS

SmithKline Beecham describes novel compounds for depression and other CNS disorders

Jan. 18, 1999

Dopamine D3 antagonists for psychoses and other D3 ligands designed at SmithKline Beecham

Jan. 15, 1999

Urea derivatives acting at multiple 5-HT receptor subtypes emerge from SB R&D

Jan. 15, 1999

Agouron's new MMP inhibitors described in patent literature

Jan. 15, 1999

Indole-based antimigraine agents in development at Allelix

Jan. 15, 1999

Cardioprotective benzoylguanidines with improved properties claimed by Hoechst

Jan. 15, 1999

Novel compounds developed at Roche for lipid disorders and fungal infections

Jan. 15, 1999

Vanadium complexes claimed by Angiotech for wide range of proliferative disorders

Jan. 14, 1999

Human mindin polypeptides and polynucleotides for angiogenic diseases

Jan. 14, 1999

Peripherally selective kappa-opioid agonists in early development at Warner-Lambert

Jan. 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...